25.32
Viral Patojenlere Karşı Bağışıklık Tepkisi
Bağışıklık sisteminin viral enfeksiyonlara tepkisi, doğal öldürücü (NK) hücreleri, T hücresi aracılı tepkiler ve antikor aracılı tepkileri içeren karm…
Viral enfeksiyon üzerine hücreler, enfekte olmamış hücreleri korumak için interferonlar salgılar ve spesifik olmayan doğuştan gelen bir bağışıklık tepkisi başlatmak için devriye gezen NK hücrelerini aktive eder.
Bu NK hücreleri, enfekte hücreler üzerindeki çeşitli viral antijenleri tanıyan ve bunları hücre lizisi ile ortadan kaldıran patojen tanıma reseptörlerine sahiptir.
Parçalanmış virüs ile enfekte olmuş hücreler, dendritik hücreler gibi APC'ler tarafından yutulan viral antijenleri serbest bırakır ve bu da onları hem MHC I hem de MHC II ile gösterir.
Antijen-MHC I kompleksi, virüs ile enfekte olmuş hücreleri öldürmek için sitotoksik T hücrelerine farklılaşan antijene özgü naif CD8 T hücrelerine sunulur.
Buna karşılık, antijen-MHC II kompleksi, antijene özgü CD4 T hücrelerini aktive ederek yardımcı T hücrelerine yol açar.
Bu hücreler, enfekte olmuş hücrelerin yok edilmesi için sitotoksik T hücresi aktivitesini arttırır.
Ek olarak, yardımcı T hücreleri, reseptörleri serbest viral partikülleri doğrudan bağlayabilen ve antikor üreten plazma hücrelerine farklılaşabilen B hücrelerini aktive eder.
Salgılanan bu antikorlar, diğer serbest viral partikülleri bağlayarak hedef hücrelere nüfuz etmelerini önler ve bunları fagositler tarafından nötralizasyon için işaretler.
View the full transcript and gain access to JoVE Core videos
Q1: What role do natural killer cells play in the initial immune response to viral infection?
Natural killer cells are activated by interferons secreted from infected cells and provide the first line of defense against viral pathogens. These cells possess pathogen recognition receptors that identify viral antigens on infected cells and eliminate them through cell lysis. NK cells also produce proinflammatory cytokines that help control viral disease progression.
Q2: How do CD8 T cells and CD4 T cells work together to eliminate virus-infected cells?
CD8 cytotoxic T cells recognize viral antigens presented on infected cells and directly kill them. CD4 helper T cells support this response by enhancing cytotoxic T cell activity and activating B cells to produce antibodies. This coordinated action ensures both direct elimination of infected cells and production of neutralizing antibodies against free viral particles.
Q3: What is the function of antibodies in protecting against viral infection?
Antibodies produced by plasma cells bind to free viral particles, preventing them from attaching to or penetrating target cells. This neutralization action stops viral spread and marks infected particles for destruction by phagocytes. Antibodies provide a critical layer of defense by blocking viral entry before infection can occur.
Q4: How do antigen-presenting cells contribute to the adaptive immune response against viruses?
Antigen-presenting cells like dendritic cells engulf viral antigens released from lysed infected cells and display them on their surface using both MHC I and MHC II molecules. MHC I complexes activate CD8 T cells to become cytotoxic killers, while MHC II complexes activate CD4 helper T cells. This dual presentation bridges innate and adaptive immunity.
Q5: What prevents an excessive immune response from causing tissue damage during viral infection?
Regulatory T cells control immune responses by suppressing overactive immune activity and limiting immunopathology. While a robust immune response is essential for clearing viral infections, regulatory T cells maintain balance to prevent the immune system from inadvertently damaging the body's own tissues during the fight against infection.
Q6: How does the innate immune response transition to the adaptive immune response during viral infection?
The innate response begins when interferons activate NK cells to kill infected cells. Viral antigens released from lysed cells are captured by antigen-presenting cells, which then activate antigen-specific T cells through MHC presentation. This transition from non-specific NK cell activity to specific T cell and B cell responses establishes adaptive immunity.
Q7: Why is understanding viral immune responses important for vaccine and therapy development?
Understanding how the immune system responds to viral pathogens through NK cells, T cells, and antibodies provides the foundation for designing effective vaccines and immunotherapies. Knowledge of antigen presentation, T cell activation, and antibody production enables researchers to develop interventions that enhance protective immunity while minimizing harmful immunopathology.